Hellenic Open University
Μέτρηση αποδοτικότητας και αποτελεσματικότητας στις υπηρεσίες υγείας: εφαρμογή στον τομέα της νεφροπάθειας στην Ελλάδα
Abstract
dc:descriptionAIM: This doctoral thesis focuses on the measurement of efficiency and effectiveness in the health care sector, and the chosen field of study is end stage renal disease (ESRD) in Greece. The specific objectives are: i) To measure, at the health system level (macro-level), technical and scale efficiency of dialysis units and to perform a longitudinal productivity analysis, while concurrently focusing on the observed differences between the public and private sectors and ii) To compare, at the medical intervention level (micro-level), the effectiveness of the three known modalities of Renal Replacement Therapy (RRT), namely in-center hemodialysis (HD), peritoneal dialysis (PD) and renal transplantation (Tx). MATERIAL AND METHODS: All dialysis units operating in Greece from 1993 (N=73) to 2004 (N=124) were involved in the measurement of efficiency. Non-parametric Data Envelopment Analysis (DEA) was used with two inputs, nurses and dialysis machines and one output, the annual number of dialysis sessions. Technical and scale efficiency were determined for every unit in each of the study years, by implementing variable and constant returns to scale (VRS, CRS), input oriented DEA models. Total Factor Productivity was measured with Malmquist’s index which was decomposed into three components indicating changes in pure technical efficiency, scale efficiency and technology. Effectiveness of RRT methods was determined with cost-utility analysis (CUA). A representative sample of patients on HD (N=642), PD (N=65) and Tx (N=167) were self-administered the KDQOL-SF (Kidney Disease Quality of Life Short Form) instrument, incorporating the generic QoL instrument SF-36, from which the preference-based SF-6D utility index was derived. Utilities were also obtained from direct methods, namely visual analog scale (VAS), time tradeoff (TTO) and standard gamble (SG), and patients’ willingness-to-pay for a kidney transplant was measured. Lifelong QALYs (Quality Adjusted Life Years) were calculated by considering individual expected remaining life years. HD and PD cost analysis was performed from the societal perspective, whereas the cost of Tx was adopted from a reimbursement proposal formulated by the Hellenic National Transplant Organization. In the CUA, both cost and QALYs were discounted at a common rate of 5%. RESULTS: The DEA VRS models, for the twelve study years, produced efficiency scores ranging from 66,18% to 74,19%. Differences are observed between the public and private sectors, with scores varying between 62,3-70,5% and 75,0-89,7% respectively. The CRS models logically produced lower scores for all units (39,5-53,5%). The scores from the VRS and CRS models are statistically significant different (P<0,001), implying the coexistence of scale inefficiencies, and these were found to vary between 25,1% και 40,9%. The Malmquist productivity index, for the study period, ranged from 0.957 and 1.040 implying annual productivity fluctuations of approximately ± 4,0%, usually following the pattern of the public dialysis units. However, the efficiency change and technological change components differed by up to 30% in cases. The basic psychometric properties, reliability and validity, of the KDQOL-SF instrument were confirmed. In all generic and disease-specific scales, transplanted patients reported better health (P<0,001), whereas the observed differences between HD and PD patients where statistically insignificant. SF-6D utilities demonstrated better validity and sensitivity compared to those derived form VAS, TTO and SG, and were chosen as QALY weights in the CUA. SF-FD scores were 0,639 (HD), 0,599 (PD) and 0,716 (Tx) (P<0,001). The annual cost per patient for HD and PD was 36.247,33 € and 30.719,25 € respectively. The cost of Tx was calculated separately for the first year and for three years after the operation, at 31.713,67 € and 42.944,39 € respectively. Cost per QALY is higher in HD (60.353,03 €) compared to PD (54.503,50 €) and 1st year Tx (45.522,66 €). CONCLUSIONS: There is noteworthy space for improvement of technical efficiency in the dialysis sector in Greece, mostly by optimizing the use of nursing staff and dialysis machines. This does not necessarily imply reducing these inputs, but rather distributing them more rationally. Furthermore, the production scale of most dialysis units requires reconsideration due to existing scale inefficiencies. The abovementioned are also reflected in the trends of the Malmquist productivity index over a twelve-year period. At the medical intervention level, the relatively higher cost of HD is the main justification for its higher resulting cost/QALY compared to PD and Tx. Considering that HD is used by 75% of the ESRD patients in Greece, efforts to reduce these costs must be intensified. This obviously involves reconsidering policies pertinent to the supply and reimbursement of dialysis filters and medication, the potential of establishing satellite dialysis units and the adoption of telemedicine in remote areas, just to mention a few. It is also obvious that a more widespread use of PD is a step in the direction of increasing cost-effectiveness. However the ultimate means of therapy is renal transplantation and conscientious efforts are required for disseminating the idea of organ donation.
Degree
thesis:*- Grantor dc:publisher
- Hellenic Open University
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kontodimopoulos, Nikolaos
- Κοντοδημόπουλος, Νικόλαος
Subjects
dc:subject × 21- Αποδοτικότητα υπηρεσιών υγείας
- Παραγωγικότητα υπηρεσιών υγείας
- Περιβάλλουσα ανάλυση δεδομένων
- Οικονομική αξιολόγηση υπηρεσιών υγείας
- Ανάλυση κόστους-χρησιμότητας
- Δείκτης Malmquist
- Ποιοτικώς προσαρμοσμένα έτη ζωής
- Θεραπεία υποκατάστασης νεφρικής λειτουργίας
- Efficiency of health services
- Productivity of health services
- Data envelopment analysis
- Economic evaluation of health services
- Cost-utility analysis
- Malmquist index
- Quality adjusted life years (QALY)
- Renal replacement therapy (RRT)
- SF-36 / SF-6D
- Κοινωνικές Επιστήμες
- Οικονομικά και Επιχειρήσεις
- Social Sciences
- Economics and Business
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/14985